Resistance to protease inhibitors and HIV-1 genetic variability in V3 region in people living with HIV/AIDS
DOI:
https://doi.org/10.5327/DST-2177-8264-2024361426Abstract
El VIH-1 se caracteriza por una amplia diversidad genética en todo el mundo, aunque en algunas zonas endémicas la diversidad genética del VIH-1 en personas bajo terapia antirretroviral (TAR) durante 10 años sigue siendo un desafío desconocido.
Downloads
References
Capel E, Martrus G, Parera M, Clotet B, Martínez MA. Evolution of the
human immunodeficiency virus type 1 protease: effects on viral replication
© 2024 Sociedade Brasileira de Doenças Sexualmente Transmissíveis
This is an open access article distributed under the terms of the Creative Commons license.
capacity and protease robustness. J Gen Virol. 2012; 93(Pt 12):2625-34.
https://doi.org/10.1099/vir.0.045492-0
Hwang SS, Boyle TJ, Lyerly HK, Cullen BR. Identification of the
envelope V3 loop as the primary determinant of cell tropism in HIV-1.
Science. 1991;253(5015):71-4. https://doi.org/10.1126/science.1905842
Duani H, Aleixo AW, Tupinambás U. Trends and predictors of HIV-1
acquired drug resistance in Minas Gerais, Brazil: 2002-2012. Braz J Infect
Dis. 2017;21(2):148-54. https://doi.org/10.1016/j.bjid.2016.11.009
Chaves YO, Pereira FR, Pinheiro RS, Batista DRL, Balieiro AAS,
Lacerda MVG, et al. High detection rate of HIV drug resistance
mutations among patients who fail combined antiretroviral therapy in
Manaus, Brazil. Biomed Res Int. 2021;8(2021):5567332. https://doi.
org/10.1155/2021/5567332
Junqueira DM, Almeida SEM. HIV-1 subtype B: traces of a pandemic.
Virology. 2016;495:173-84. https://doi.org/10.1016/j.virol.2016.05.003
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Brazilian Journal of Sexually Transmitted Diseases
This work is licensed under a Creative Commons Attribution 4.0 International License.
